(Q85706040)

English

Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: part II. Autologous Transplantation-novel agents and immunomodulatory

scientific article published on 07 September 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24018393%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: part II. Autologous Transplantation-novel agents and immunomodulatory strategies (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24018393%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Parameswaran Hari

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24018393%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

5

object named as

Sergio A Giralt

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24018393%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

author name string

David Avigan

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24018393%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Minoo Battiwalla

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24018393%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Michael R Bishop

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24018393%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Nancy M Hardy

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24018393%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Nicolaus Kröger

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24018393%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Alan S Wayne

8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24018393%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Katharine C Hsu

9

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24018393%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

publication date

7 September 2013

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24018393%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Biology of Blood and Marrow Transplantation

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24018393%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

19

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24018393%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

12

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24018393%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1661-1669

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24018393%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Biologic activity of irradiated, autologous, GM-CSF-secreting leukemia cell vaccines early after allogeneic stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dendritic cells: development, function and potential use for cancer immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Whole-genome sequencing of multiple myeloma from diagnosis to plasma cell leukemia reveals genomic initiating events, evolution, and clonal tides

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term prognostic significance of response in multiple myeloma after stem cell transplantation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salvage second hematopoietic cell transplantation in myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic hematopoietic stem cell transplantation for multiple myeloma: curative but not the standard of care

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PD-1 and its ligands in T-cell immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transfer of influenza vaccine-primed costimulated autologous T cells after stem cell transplantation for multiple myeloma leads to reconstitution of influenza immunity: results of a randomized clinical trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clonal competition with alternating dominance in multiple myeloma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Superiority of the triple combination of bortezomib-thalidomide-dexamethasone over the dual combination of thalidomide-dexamethasone in patients with multiple myeloma progressing or relapsing after autologous transplantation: the MMVAR/IFM 2005-04 R

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Superior 12-year survival after at least 4-year continuous remission with tandem transplantations for multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vaccination with dendritic cell/tumor fusion cells results in cellular and humoral antitumor immune responses in patients with multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ex vivo characterization of polyclonal memory CD8+ T-cell responses to PRAME-specific peptides in patients with acute lymphoblastic leukemia and acute and chronic myeloid leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fusion of dendritic cells with multiple myeloma cells results in maturation and enhanced antigen presentation

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination immunotherapy with prostate GVAX and ipilimumab: safety and toxicity.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Generation of tumor-specific T lymphocytes using dendritic cell/tumor fusions and anti-CD3/CD28

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of immunofixation, serum free light chain, and immunophenotyping for response evaluation and prognostication in multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunotherapy for patients with acute myeloid leukemia using autologous dendritic cells generated from leukemic blasts

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Graft-versus-myeloma effect: proof of principle

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Breaking tolerance to self, circulating natural killer cells expressing inhibitory KIR for non-self HLA exhibit effector function after T cell-depleted allogeneic hematopoietic cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Latest advances and current challenges in the treatment of multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeted T-cell therapy for human leukemia: cytotoxic T lymphocytes specific for a peptide derived from proteinase 3 preferentially lyse human myeloid leukemia cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Complete remission in a patient with recurrent acute myeloid leukemia induced by vaccination with WT1 peptide in the absence of hematological or renal toxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of the immune system of multiple myeloma patients achieving long-term disease control by multidimensional flow cytometry.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical course of patients with relapsed multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of relapsed and relapsed/refractory multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term follow-up of a comparison of nonmyeloablative allografting with autografting for newly diagnosed myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular remission after allogeneic or autologous transplantation of hematopoietic stem cells for multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification and characterization of epitopes of the receptor for hyaluronic acid-mediated motility (RHAMM/CD168) recognized by CD8+ T cells of HLA-A2-positive patients with acute myeloid leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improvement in long-term outcomes with successive Total Therapy trials for multiple myeloma: are patients now being cured?

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

RHAMM-R3 peptide vaccination in patients with acute myeloid leukemia, myelodysplastic syndrome, and multiple myeloma elicits immunologic and clinical responses

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD8 T-cell responses to Wilms tumor gene product WT1 and proteinase 3 in patients with acute myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of a new HLA-A2-restricted T-cell epitope within HM1.24 as immunotherapy target for multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Minimal residual disease in myeloma: are we there yet?

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-risk cytogenetics and persistent minimal residual disease by multiparameter flow cytometry predict unsustained complete response after autologous stem cell transplantation in multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sperm protein 17 is a novel cancer-testis antigen in multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ipilimumab for metastatic melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

KIR2DS1-positive NK cells mediate alloresponse against the C2 HLA-KIR ligand group in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibitory KIR-HLA receptor-ligand mismatch in autologous haematopoietic stem cell transplantation for solid tumour and lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Flow cytometric disease monitoring in multiple myeloma: the relationship between normal and neoplastic plasma cells predicts outcome after transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PD-1 blockade by CT-011, anti-PD-1 antibody, enhances ex vivo T-cell responses to autologous dendritic cell/myeloma fusion vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular and clinical remissions in multiple myeloma: role of autologous and allogeneic transplantation of hematopoietic cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early lymphocyte recovery is a predictive factor for prolonged survival after autologous hematopoietic stem cell transplantation for acute myelogenous leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Licensing of natural killer cells by host major histocompatibility complex class I molecules

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aurora-A kinase: a novel target of cellular immunotherapy for leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of allografting with autografting for newly diagnosed myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sustaining the graft-versus-tumor effect through posttransplant immunization with granulocyte-macrophage colony-stimulating factor (GM-CSF)-producing tumor vaccines

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer immunotherapy via dendritic cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular remission after myeloablative allogeneic stem cell transplantation predicts a better relapse-free survival in patients with multiple myeloma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Donor lymphocyte infusions for multiple myeloma: clinical results and novel perspectives

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Severe herpesvirus infections in an adolescent without natural killer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDS.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PD-1 and its ligands in tolerance and immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Idiotype-pulsed antigen-presenting cells following autologous transplantation for multiple myeloma may be associated with prolonged survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Minimal residual disease assessed by multiparameter flow cytometry in multiple myeloma: impact on outcome in the Medical Research Council Myeloma IX Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

X-linked lymphoproliferative syndrome: a genetic condition typified by the triad of infection, immunodeficiency and lymphoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunity to WT1 in the animal model and in patients with acute myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The epithelial tumor antigen MUC1 is expressed in hematological malignancies and is recognized by MUC1-specific cytotoxic T-lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: Part I. Biology of relapse after transplantation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tandem autologous vs autologous plus reduced intensity allogeneic transplantation in the upfront management of multiple myeloma: meta-analysis of trials with biological assignment

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Different patterns of relapse after autologous peripheral blood stem cell transplantation in multiple myeloma: clinical results of 280 cases from the Spanish Registry.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

International uniform response criteria for multiple myeloma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

NY-ESO-1 immunotherapy for multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I/II study of vaccination with dendritic-like leukaemia cells for the immunotherapy of acute myeloid leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination immunotherapy using adoptive T-cell transfer and tumor antigen vaccination on the basis of hTERT and survivin after ASCT for myeloma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of natural killer cells in immunity against multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autologous/reduced-intensity allogeneic stem cell transplantation vs autologous transplantation in multiple myeloma: long-term results of the EBMT-NMAM2000 study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Granulocyte-macrophage colony-stimulating factor (GM-CSF)-secreting cellular immunotherapy in combination with autologous stem cell transplantation (ASCT) as postremission therapy for acute myeloid leukemia (AML).

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Novel agents improve survival of transplant patients with multiple myeloma including those with high-risk disease defined by early relapse (<12 months)

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved survival in multiple myeloma and the impact of novel therapies

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ipilimumab: an anti-CTLA-4 antibody for metastatic melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Higher infused lymphocyte dose predicts higher lymphocyte recovery, which in turn, predicts superior overall survival following autologous hematopoietic stem cell transplantation for multiple myeloma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HLA class I-restricted lysis of leukemia cells by a CD8(+) cytotoxic T-lymphocyte clone specific for WT1 peptide

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term WT1 peptide vaccination for patients with acute myeloid leukemia with minimal residual disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/24018393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.BBMT.2013.08.011

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24018393%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24018393%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24018393%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q85706040&oldid=2120879183"